CTRA vs MIRA · P/E 15, rev $7.64B vs $41.1M cap
Coterra Energy Inc (CTRA) versus MIRA Pharmaceuticals, Inc. Common Stock (MIRA) — a side-by-side from cached financials, not a winner call.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a drug manufacturers - general company listed on NASDAQ.
Latest reported CTRA revenue for 2025-12-31 was $7.64B. Net income was $1.72B. Revenue was up 40.1% from 2024-12-31 to 2025-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
MIRA does not have a complete income-statement cache yet.
CTRA currently screens at market cap $20.46B and trailing P/E 15.2. MIRA currently screens at market cap $41.1M.
Not investment advice. Open the CTRA and MIRA stock pages for the full models.
Not investment advice.